MC TOXICOLOGY CONSULTING GMBH
Desconocido
iMPact: Novel, orally available immune modulator MP1032 with anti-SARS-CoV-2 and anti-cytokine activity
MC TOXICOLOGY CONSULTING GMBH
participó en un
HORIZON EUROPE:
HORIZON-HLTH-2021-CORONA-01
The current global COVID-19 pandemic has caused severe health and socio-economic challenges. Despite significant improvements in the treatme...
2021-11-16 - 2023-04-30 | Financiado
2021-11-16 - 2023-04-30 | Financiado
CureCN: Adeno Associated Virus Vector Mediated Liver Gene Therapy for Crigler Najjar Syndrome
MC TOXICOLOGY CONSULTING GMBH
participó en un
H2020:
H2020-SC1-2016-2017
Crigler-Najjar syndrome (CN) is a rare recessive disorder caused by mutations in the uridine diphosphate glucuronosyltransferase 1A1(UGT1A1)...
2017-12-05 - 2023-12-31 | Financiado
2017-12-05 - 2023-12-31 | Financiado
* No se disponen de datos de la empresa actual.